BCHE and Alzheimer disease: Currently approved drugs for the treatment of Alzheimer’s disease (AD) mainly include cholinesterase inhibitors (such as Donepezil, rivastigmine, galantamine) and NMDA receptor antagonists (such as Memantine) (Wu et al., 2023).